RecruitingNot ApplicableNCT06974136

tES Modalities for the Treatment of ADHD

Transcranial Electrical Stimulation Modalities for the Treatment of Clinical Symptoms and Cognitive Deficits in Attention-deficit Hyperactivity Disorder Disorder

Sponsor

The National Brain Mapping Laboratory (NBML)

Enrollment

45 participants

Start Date

Mar 30, 2025

Study Type

INTERVENTIONAL

Conditions

Neurodevelopmental Disorders Attention Deficit Disorder with Hyperactivity

Summary

This project investigates the efficacy of transcranial electrical stimulation (tES) modalities, specifically transcranial direct current stimulation (tDCS) and transcranial alternating current stimulation (tACS), for treating Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adolescents.

Eligibility

Min Age: 7 YearsMax Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called transcranial electrical stimulation for people with attention deficit disorder with hyperactivity and neurodevelopmental disorders. The study is currently recruiting participants at 1 location. People eligible for this study include aged 7 Years to 18 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEtranscranial electrical stimulation

Transcranial electrical stimulation (tES) is a non-invasive neuromodulation technique that applies low-intensity electrical currents to the scalp to modulate brain activity. It targets specific brain regions to influence neuronal excitability, connectivity, and plasticity, offering potential therapeutic benefits for neurological and psychiatric conditions. tES is portable, cost-effective, and generally well-tolerated, with minimal side effects such as mild tingling or itching at the stimulation site.